Back to Markets
IPCentury Therapeutics Inc

Century Therapeutics Inc

IPSCNASDAQ NMS - GLOBAL MARKET
Health CareBiotechnology

$2.45

+0.0700 (+2.73%)

As of 05/29/26 EDT · USD

Compare
Low: $0.4400Current: $2.45High: $3.04

Key Statistics

Open

$2.39

Day High

$2.45

Day Low

$2.32

Prev. Close

$2.39

VolumeShares traded today.

1.19M

Avg. VolumeAverage daily volume.

Market CapTotal value of all shares = price × shares outstanding.

$441.87M

P/E (TTM)Price-to-Earnings: share price ÷ earnings per share over the last 12 months. Lower can mean cheaper; very high can mean growth expectations.

-2.21

Forward P/EP/E based on forecast next-year earnings.

P/B RatioPrice-to-Book: share price ÷ book value per share.

52W HighHighest price over the past 52 weeks.

$3.04

52W LowLowest price over the past 52 weeks.

$0.4400

50D MAAverage closing price over the last 50 trading days.

$2.28

200D MAAverage closing price over the last 200 trading days.

$1.39

Dividend YieldAnnual dividend ÷ share price, as a %.

BetaVolatility vs the market. >1 = more volatile than the S&P 500.

Performance

1W

+7.9%

1M

+11.4%

6M

+360.5%

YTD

+146.3%

1Y

+361.9%

About

Regulus Therapeutics Inc. is a clinical stage biopharmaceutical company focused on the development of first-in-class drugs that target microRNAs to treat a broad range of diseases. Regulus was established in September 2007 by Alnylam Pharmaceuticals and Isis Pharmaceuticals.

www.centurytx.com/

Company Facts

SectorHealth Care
IndustryBiotechnology
ExchangeNASDAQ NMS - GLOBAL MARKET
CurrencyUSD

Sentiment

Latest News

Social Noise

Price Alerts

Loading…

Trade IPSC

Brokers available in your region (US)

Affiliate links — we may earn a commission. CFDs are risky.